Veterinary Medicines

Supaverm Oral Suspension

Authorised
  • Mebendazole
  • Closantel sodium dihydrate
Download as PDF

Product identification

Medicine name:
Supaverm Oral Suspension
Active substance:
  • Mebendazole
  • Closantel sodium dihydrate
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Mebendazole
    75.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Closantel sodium dihydrate
    54.37
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        65
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC09
  • QP52AG09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Container: Polyethylene bottles of 20 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 10 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 5 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 2.5 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 1 litre containing a white suspension.Closure: Ureum screw cap with HDPE insert.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lusomedicamenta Sociedade Tecnica Farmaceutica S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22020/031/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."